1. Health Wealth & Happiness Presented by Waqar Yaqoob [email protected] Skype: xs2vicky 0313-8565677 2. GOOD MORNING & WELCOME Please Switch Your Mobile Phone…

Vasopeptidase Inhibition: A New Direction in Cardiovascular Treatment . By: Dr. HARMANJIT SINGH MD STUDENT , GMC , PATIALA INTRODUCTION Essential hypertension remains one…

View from the NKF-KDOQI Diabetes and Chronic Kidney Disease Work Group Katherine R. Tuttle, MD, FASN, FACP Medical and Scientific Director Providence Medical Research Center…

  Role of RAAS inhibition in the Management of Hypertension Dr KyawSoe Win MBBS, M Med Sc (Int Med), MRCPUK, FRCPE, FAsCC, FAPSIC Asso: Prof / Senoir Consultant Cardiologist…

Slide 1Fibrillation Auriculaire: Thérapies en Amont Fibrillation Auriculaire: Thérapies en Amont Gerald V. Naccarelli M.D. Research support: Boston-Scientific, Sanofi-Aventis,…

Slide 1 Sharma Prabhakar MD MBA FACP FASN Professor and Chief, Nephrology Division Texas Tech University Health Sciences Center “Angiotensin-Insulin Cross Talk” Implications…

Slide 1On behalf of the CHARM Programme Investigators and Committees Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity CHARM Slide 2 2 Background…

Slide 1 E. Gronda, MD, FESC Cardiology Division Cardiovascular Department IRCCS, H S. Giuseppe, MultiMedica, Group S.S. Giovanni - Milano “Can Neurohormonal Antagonists…

Slide 1 ASTORASTOR Alport Syndrome Treatments and Outcomes Registry Alport Syndrome Family Conference Alport Syndrome Registries Clifford E. Kashtan, M.D. University of Minnesota…

Slide 1 1 Giuseppe Remuzzi Prevention of progression and remission/regression strategies of chronic renal diseases: can we do better now than 5 years ago? Bellagio, March…